Received Dec 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
he has gotten the cold twice; This non-serious case was reported by a consumer via call center representative and described the occurrence of cold in a male patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced cold (Verbatim: he has gotten the cold twice). The outcome of the cold was unknown. It was unknown if the reporter considered the cold to be related to Arexvy. It was unknown if the company considered the cold to be related to Arexvy. Additional Information: GSK Receipt Date: 18-DEC-2025 The reporter was a patient who stated he had been part of a clinical trial for Arexvy and had received a dose 2 years before the trial ended. He stated that since then he had gotten the cold twice. The batch number was not provided, and we are unable to contact the reporter.